3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Suspended
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Lymphoma, Follicular
5
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hodgkin Disease
4
Congenital Abnormalities
4
Burkitt Lymphoma
4
Blast Crisis
4
Sezary Syndrome
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Mycosis Fungoides
3
Leukemia, Myeloid, Acute
3
Recurrence
2
Primary Myelofibrosis
2
Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Extranodal NK-T-Cell
2
Interventions
tocilizumab
1
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Neuropsychological Tests
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Lopinavir
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Contrast Media
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Cytokine Release Syndrome
×
Methylprednisolone
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled